NuVasive (NUVA) is down 10.8%, and Medtronic (MDT) is down 1.6%, after a jury found the companies guilty of infringing each others' patents, but awarded Medtronic far more in damages. However, Jefferies remains bullish on NuVasive, predicting market share gains for the company's XLIF spinal procedure will allow it to beat guidance.
NuVasive (NUVA) is down 10.8%, and Medtronic (MDT) is down 1.6%, after a jury found the...
From other sites
Video at CNBC.com (Jul 13, 2016)
Video at CNBC.com (Jun 3, 2016)
at CNBC.com (Oct 4, 2012)
at CNBC.com (Oct 3, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs